Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression

Lignende værker

• High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
  af: Tian, Yu-Feng, et al.
  Udgivet: (2017)
• Low thrombospondin 2 expression is predictive of low tumor regression after neoadjuvant chemoradiotherapy in rectal cancer
  af: Lin, Cheng-Yi, et al.
  Udgivet: (2015)
• High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
  af: Lin, Ching-Yih, et al.
  Udgivet: (2017)
• Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy
  af: Lee, Yi-Ying, et al.
  Udgivet: (2017)
• The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
  af: Meng, Xiangjiao, et al.
  Udgivet: (2014)